For the quarter ending 2025-12-31, AFRM had -$3,038K decrease in cash & cash equivalents over the period. $118,034K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net income (loss) | 129,586 | 80,694 | 69,244 | 2,804 |
| Provision for losses | 214,153 | 162,752 | 156,627 | 147,252 |
| Amortization of premiums and discounts on loans | 78,927 | 65,072 | 61,972 | 60,530 |
| Gain on sales of loans | 185,231 | 119,049 | 116,883 | 75,839 |
| Gain on extinguishment of debt | 42 | 1,495 | 0 | 0 |
| Changes in fair value of assets and liabilities | -2,015 | 110 | -1,690 | -834 |
| Amortization of commercial agreement assets | 4,759 | 8,056 | 7,968 | 39,424 |
| Amortization of debt issuance costs | 7,244 | 6,828 | 7,091 | 10,308 |
| Amortization of discount on securities available for sale | - | - | -9,849 | -7,564 |
| Accrued interest on securities available for sale | 8,313 | 9,959 | - | - |
| Commercial agreement warrant expense | -61,207 | -40,977 | -41,460 | -36,063 |
| Stock-based compensation | 77,800 | 85,853 | 65,495 | 75,607 |
| Depreciation and amortization | 75,593 | 65,329 | 63,995 | 59,467 |
| Impairment of right of use assets | - | - | 0 | - |
| Other | 14,165 | 4,930 | -3,723 | -9,980 |
| Purchases and origination of loans held for sale | 728,196 | 749,202 | 338,211 | 789,323 |
| Proceeds from the sale of loans held for sale | 727,912 | 748,761 | 338,187 | 789,362 |
| Accounts receivable, net | -11,054 | -138,862 | 208,849 | 19,884 |
| Other assets | 69,985 | -30,955 | -5,817 | -9,429 |
| Accounts payable | -791 | -24,801 | 41,762 | -9,568 |
| Payable to third-party loan buyers | -63,462 | -17,910 | 34,703 | 19,751 |
| Accrued interest payable | 3,433 | 1,621 | 2,769 | -2,277 |
| Accrued expenses and other liabilities | 8,091 | -3,586 | -30,130 | 1,453 |
| Net cash provided by operating activities | 173,738 | 374,572 | 74,637 | 210,388 |
| Purchases and origination of loans held for investment | 12,665,105 | 9,797,362 | 9,817,626 | 7,676,063 |
| Proceeds from the sale of loans held for investment | 5,323,088 | 4,282,839 | 4,449,448 | 2,858,471 |
| Principal repayments and other loan servicing activity | 5,890,329 | 5,359,253 | 5,005,990 | 4,988,174 |
| Acquisition, net of cash and restricted cash acquired | - | - | 0 | - |
| Additions to property, equipment and software | 55,704 | 54,365 | 51,120 | 53,012 |
| Purchases of securities available for sale | 67,935 | 146,462 | 270,291 | 368,710 |
| Proceeds from maturities and repayments of securities available for sale | 210,251 | 216,425 | 231,390 | 263,817 |
| Other investing inflows | 80 | 61 | 99,917 | - |
| Other investing cash inflows/(outflows) | - | - | - | -22,841 |
| Other investing outflows | 0 | 0 | 65,000 | - |
| Net cash used in investing activities | -1,364,997 | -139,611 | -454,514 | 35,517 |
| Proceeds from the issuance of convertible notes | 0 | - | 0 | 0 |
| Proceeds from the issuance of funding debt | 9,292,589 | 7,980,435 | 7,150,247 | 6,130,641 |
| Proceeds from issuance of notes and certificates by securitization trust | 0 | 1,100,000 | 750,000 | 1,000,000 |
| Principal repayments of funding debt | 8,032,176 | 7,818,589 | 7,455,067 | 6,383,990 |
| Principal repayments of notes issued by securitization trust | 0 | 1,100,000 | 0 | 900,000 |
| Payment of debt issuance costs | 1,230 | 9,466 | 6,474 | 19,689 |
| Extinguishment of convertible debt | 944 | 24,814 | 0 | 0 |
| Proceeds from exercise of common stock options and warrants and contributions to espp | 9,270 | 94,828 | 10,777 | 10,527 |
| Payments of tax withholding for stock-based compensation | - | - | 62,225 | 83,043 |
| Repurchase of common stock | 0 | - | 0 | 0 |
| Taxes paid related to net share settlement of equity awards | 80,929 | 112,307 | - | - |
| Net cash provided by financing activities | 1,186,580 | 110,086 | 387,259 | -245,555 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,642 | -3,861 | 13,083 | -1,548 |
| Net increase in cash, cash equivalents and restricted cash | -3,038 | 341,187 | 20,464 | -1,198 |
| Cash and cash equivalents at beginning of period | 2,097,610 | 1,756,423 | 1,735,959 | 1,737,157 |
| Cash and cash equivalents at end of period | 2,094,572 | 2,097,610 | 1,756,423 | 1,735,959 |
Affirm Holdings, Inc. (AFRM)
Affirm Holdings, Inc. (AFRM)